AGN News and Press, Allergan plc From 04/25/19

DUBLIN , April 25, 2019 /PRNewswire/ -- Allergan plc, (NYSE: AGN), a leading global pharmaceutical company with a more than 70-year heritage in eye care, will present new data at the Annual Meeting of The Association for Research in Vision and Ophthalmology (ARVO) to be held in Vanc...

Actionable Conclusions (1-10): Analysts Estimated 15.26% To 49.62% Net Gains For 10 Top Kiplinger Billionaire Choice Dogs Come 2020 Four of 10 top Kiplinger billionaire class dividend stocks by yield were among the top 10 gainers for the coming year based on analyst one-year target p...

Laurence Doud III, former CEO of Rochester Drug Co-Operative, was indicted yesterday by a Manhattan federal grand jury on charges of narcotics conspiracy and conspiracy to defraud the Drug Enforcement Administration (DEA) related to the distribution of "tens of millions" of opioid painkill...

Overview With no current viable treatment options, NASH remains a debilitating disease that hundreds of companies are chasing after. Due to its non-existent list of treatment options that are effective, there is a massive demand. Growing at a CAGR of over 60%, companies are pushing to be fir...

The U.S. Depart of Justice has charged 60 people , including 31 physicians, with illegally prescribing and distributing opioid painkillers. The DOJ claims that the group, which includes 53 medical professionals, are tied to ~350K prescriptions and 32M pills. More news on: Endo Internation...

Investors in biotechs and biopharma firms appear to have intensified their profit-taking after the Q1 run-up, stoked, no doubt, from the sour mood in Congress over high drug prices and the Trump administration's stated priority to tackle the problem. More news on: SPDR Biotech ETF, SPDR S&...

Minerva Neurosciences ( NERV ) is set to report data from multiple clinical trials in 2019 but roluperidone, which NERV is developing as a treatment for the negative symptoms of schizophrenia, is likely to get a disproportionate amount of attention. NERV and others developing in the negative...

CINCINNATI , April 15, 2019 /PRNewswire/ -- A new study by the University of Cincinnati Economics Center finds that the Ohio operations of biopharmaceutical company Allergan have a significant impact on the state's economy and communities. The study finds that the annual economic...

DUBLIN , April 15, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that both leading independent proxy advisory firms, Institutional Shareholder Services Inc. ("ISS") and Glass Lewis & Co. ("Glass Lewis"), have recommended that the Company's shareholders vote FOR ...

DUBLIN , April 10, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that it has received the 2019 ENERGY STAR ® Partner of the Year Sustained Excellence Award for its continued leadership in energy management and efficiency. The...